Open innovation in cancer can manifest in various forms, such as collaborative platforms, data-sharing initiatives, and joint ventures. For instance, platforms like Genomic Data Commons provide researchers access to vast genomic data sets, enabling them to identify potential biomarkers and therapeutic targets. Similarly, initiatives like The Cancer Genome Atlas facilitate the sharing of cancer genome data to help researchers understand the genetic basis of cancer.
